CTOs on the Move

Giuseppe Space Enterprises

www.giuseppespace.space

 
Giuseppe Space Enterprises is a company that specializes in the implementation, integration, and optimization of various tools and technologies into standardized system engineering/integration processes and workflows. They are committed to advancing th...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Center for Industrial Training

Center for Industrial Training is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Center for Industrial Training is based in Mechanicsburg, PA. You can find more information on Center for Industrial Training at www.cparc.org

Green Tea HP

Green Tea HP is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hologram Sciences

Reimagining the future of nutrition

Adar Medical Uniforms

The Adar Medical Uniforms brand has been well known in the medical uniforms industry since 1971. That`s over 40 years of experience providing top of line uniforms and excellent customer service. Our products are known for their fine quality, comfort, and fashionable styling. The Adar development team spends hours on end creating beautiful thought out designs that are also practical to the discerning professional. Each style is inspected and reviewed assuring that the uniforms are of the highest quality.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.